Evaluation of Unipeg® for Response and Ongoing Safety in Pakistani Population

NCT02601976 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Peginterferon alfa-2a
DRUG: Ribavirin

Sponsor

Getz Pharma

Collaborators

[object Object]